Which muscle relaxants should be used in day surgery and when

Current Opinion in Anaesthesiology

Volumn 19, Issue 6, 2006, Pages 600-605

  Bettelli, Gabriella ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Ambulatory anaesthesia; Ambulatory surgery; Myalgia; Neuromuscular blocking agents; Postoperative residual curarization; Sugammadex

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANESTHETIC AGENT; ATRACURIUM; BENZYLISOQUINOLINE DERIVATIVE; CHELATING AGENT; CISATRACURIUM; DICLOFENAC; MIVACURIUM; MUSCLE RELAXANT AGENT; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PANCURONIUM; PROPOFOL; ROCURONIUM; SODIUM CHANNEL BLOCKING AGENT; STEROID; SUGAMMADEX; SUXAMETHONIUM; THIOPENTAL; TUBOCURARINE CHLORIDE; VECURONIUM;

ABSENCE OF SIDE EFFECTS; AMBULATORY SURGERY; BLURRED VISION; CARDIOVASCULAR DISEASE; DIPLOPIA; DRUG INDUCED HEADACHE; EAR NOSE THROAT SURGERY; ENDOTRACHEAL INTUBATION; EYE SURGERY; FASCICULATION; GENERAL ANESTHESIA; HUMAN; HYPERKALEMIA; INCIDENTAL FINDING; INTRACRANIAL HYPERTENSION; INTRAOCULAR HYPERTENSION; INTUBATION; LAPAROSCOPY; LARYNX DISORDER; LOCAL ANESTHESIA; MALIGNANT HYPERTHERMIA; MANDATORY TESTING; MUSCLE RELAXATION; MUSCLE WEAKNESS; MYALGIA; MYOGLOBINEMIA; NERVE BLOCK; ORTHOSTATIC HYPOTENSION; OUTPATIENT DEPARTMENT; PAIN ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW; RISK REDUCTION; SCORING SYSTEM; SIDE EFFECT; SORE THROAT; STOMACH DISEASE; STOMACH PRESSURE; URINE RETENTION;

AMBULATORY SURGICAL PROCEDURES; ANESTHESIA, CONDUCTION; ANESTHESIA, GENERAL; BENZYLISOQUINOLINES; CHOLINESTERASE INHIBITORS; GAMMA-CYCLODEXTRINS; HUMANS; INTUBATION, INTRATRACHEAL; ISOQUINOLINES; MUSCLE RELAXANTS, CENTRAL; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PAIN, POSTOPERATIVE; PARALYSIS; POSTOPERATIVE NAUSEA AND VOMITING; PRACTICE GUIDELINES; RISK ASSESSMENT; STEROIDS; SUCCINYLCHOLINE;

EID: 33750874348     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32801062eb     Document Type: Review

References (47)

1. White P. Ambulatory anesthesia advancements into the new millennium. Anest Analg 2000; 90:1234-1235.
2. Bornowski RG. Ambulatory anesthesia: preventing perioperative complications. Clev Clin J Med 2006; 73 (Suppl 1):57-61.
3. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia [editorial]. Br J Anaesth 2000; 84:301-303
4. Basta SJ. Muscle relaxant and reversal agents. In: White PF, editor. Ambulatory anesthesia & surgery. London: WB Saunders; 1997. pp. 394-405.
5. Crul JF. Muscle relaxants for outpatient procedures. Acta Anaesthesiol Belg 1985; 36:401-405.
6. Ding Y, Fredman B, White PF. Use of mivacurium during laparoscopic surgery: effect of reversal drugs on postoperative recovery. Anesth Analg 1994; 78:450-454.
7. Bevan DR, Donati F. Suxamethonium in clinical praxis. In: Booij LHDJ, editor. Neuromuscular transmission. London: BMJ Publishing Group; 1986. p. 84.
8. Rosemberg H, Gronart GA. Intractable cardiac arrest in children given succinylcoline. Anesthesiology 1054; 77:.
9. Savaresev JJ, Ali HH, Basta SJ, Embree PB. The clinical neuromuscular pharmacology of mivacurium chloride (BW B 109 OU): a short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1998;68:723-732.
10. White PF. Role of rapid short acting anesthetics, analgesics and muscle relaxants in ambulatory anesthesia. Acta Anaesthesiol Scand Suppl 1997;111:223-226.
11. Bowman WC. Neuromuscular block. Br J Pharmacol 2006; 147 (Suppl 1):S277-S286. From descriptions of the South American arrow poisons known as curares to rocuronium and its novel antagonist, a particular cyclodextrin, which chelates the drug, removes it from the acetylcholine receptors.
12. -1) in adult patients with and without renal failure. Eur J Anaesthesiol 2005; 22:929-932.
13. Cook DR. Can succinylcholine be abandoned? Anaesth Analg 2000;990:24-28.
14. Bevan JC, Collins L, Fowler C. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anaesth Analg 1999;89:333-339.
15. Geldner G, Wulf H. Muscle relaxants suitable for day case surgery. Eur J Anaesthesiol Suppl 2001; 23:43-46.
16. Kehlet H, White P. Optimizing anesthesia for inguinal herniorraphy: general, regional or local anaesthesia? Anesth Analg 2001; 93:1367-1369.
17. Hadzic A, Kerimoglu B, Loreio D, et al. Paravertebral blocks provide superior same-day recovery over general anaesthesia for patients undergoing inguinal hernia repair. Anesth Analg 2006; 102:1076-1081.
18. Liu SS, Strodbeck WM, Richman JM, Wu CL. A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials. Anesth Analg 2005; 101:1634-1642. In this review, 1003 outpatients and seven trials are metaanalysed: potential advantages for regional anaesthesia are enlightened, but neither central neuraxial block nor peripheral nerve block are associated with reduced ambulatory surgery unit time.
19. Bulow K, Nielsen TG, Lund J. The effect of topical lignocaine on intubating conditions after propofol-alfentanil induction. Acta Anaesth Scand 1996;40:752-756.
20. Collins L, Prentice J, Vaghadia H. Tracheal intubation of outpatients with and without muscle relaxants. Can J Anaesth 2000; 47:427-432.
21. Wong AK, Teoh GS. Intubating without muscle relaxant: an alternative technique for rapid tracheal intubation. Anesth Intensive Care 1996; 24:224-230.
22. Billard V, Moulla F, Bourgain JL, et al. Hemodynamic response to induction and intubation: propofol-fentanyl interaction. Anesthesiology 1994; 81:1384-1393.
23. Barclay K, Eggers K, Asai T. Low-dose rocuronium improves conditions for tracheal intubation after induction of anaesthesia with propofol and alfentanil. Br J Anaesth 1997; 78:92-94.
24. Schlaich N, Mertzlufft F, Soltesz F, Fuchs-Buder T. Remifentanil and propofol without muscle relaxants or with different doses of rocuronium for tracheal intubation in outpatient anaesthesia. Acta Anaesthesiol Scand 2000; 44:720-769.
25. Mencke T, Echternach M, Kleinschmidt S, et al. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology 2003; 98:1049-1056.
26. Mencke T, Echternach M, Plinkert PK, et al. Does the timing of tracheal intubation based on neuromuscular monitoring decrease laryngeal injury? A randomized, prospective, controlled trial. Anaesth Analg 2006; 102:306-312. Interesting study on two different methods to select optimal intubating conditions.
27. Maltby JR, Beriault MB, Watson MC, et al. The LMA-ProSeal is an effective alternative to tracheal intubation for laparoscopic colecystectomy. Can J Anaesth 2002; 49:857-862.
28. Maltby JR, Beriault MB, Watson MC, et al. LMA Classic and LMA ProSeal are effective alternatives to endotracheal intubation for gynaecologic laparoscopy. Can J Anaesth 2003; 50:71-77.
29. Gerges FJ, Kanazi GE, Jabbour-khoury SI. Anesthesia for laparoscopy: a review. J Clin Anesth 2006; 18:67-78. Pathophysiological changes occurring during laparoscopic surgery, possible general, neuraxial, regional and local anaesthesia techniques are examined, for this increasingly common outpatient procedure.
30. Lu PP, Brimacombe J, Yang C, Shyr M. ProSeal versus the classic laryngeal mask airway for positive pressure ventilation during laparoscopic cholecystectomy. Br J Anaesth 2002; 88:824-827.
31. Trepanier C, Brousseau C, Lacerte L. Myalgia in outpatient surgery: comparison of atracurium and succinylcoline. Can J Anaesth 1988; 35 (3 Pt 1):255-259.
32. Zahl K, Apfelbaum JL. Muscle pain occurs after outpatient laparoscopy despite the substitution of vecuronium for succinylcoline. Anesthesiology 1989; 70:408-411.
33. Schreiber JU, Lysakowski C, Fuchs-Buder T, Tramer MR. Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials. Anesthesiology 2005; 103:877-884. Fifty-two randomized controlled trials are metaanalysed: the authors conclude that clinicians have to choose whether it is worthwhile using a small dose of succinylcholine to shorten recovery and apnoea period at the price of increasing the risk of postoperative myalgia.
34. Paul M, Callahan R, Au J, et al. Antiemetics of the 5-hydroxytryptamine 3A antagonist class inhibit muscle nicotinic acetylcholine receptors. Anesth Analg 2005; 101:715-721.
35. Erikson LI, Sato M, Severinghaus JW. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 1993; 78:693-699.
36. Shorten GD. Postoperative residual curarization: incidence, aethiology and associated morbidity. Anaesth Intens Care 1993; 21:782-789.
37. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: a prospective, randomized and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-2003.
38. Baillard C, Gehan G, Reboul-Marty J. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84:394-395.
39. Cammu G, de Baerdemaeker L, den Blauwen N, et al. Postoperative residual curarization with cisatracurium and rocuronium infusions. Eur J Anaest 2002; 19:129-134.
40. Beaussier M, Boughaba MA. Curarisation résiduelle [Residual neuromuscular blockade]. Ann Fran Anes Rèanim 2005; 24:1266-1274. A 'mise a point' on recurrence of postoperative residual curarization.
41. Cammu G. Postoperativge residual curarization: complication or malpractice? Acta Anaesthesiol Belg 2004; 55:245-249.
42. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolariziong muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1042-1048.
43. Cammu G, De Witte J, De Veydler J, et al. Postoperative residual paralysis in outpatients versus inpatients. Anaesth Analg 2006; 102:426-429.
44. Fuchs-Buder T, Mencke T. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting). Eur J Anaesthesiol 2001; 23 (Suppl):53-59.
45. Cheng CR, Sessler DI, Apfel CC. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting? Anaesth Analg 2005; 101:1349-1355. The latest review on the relationship between neostigmine as reversal agent and postoperative emetic events.
46. Shields M, Giovanelli M, Mirakhur RK, et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96:36-43.
47. Kopman AF. Sugammadex: a revolutionary approach to neuromuscular antagonism [editorial]. Anesthesiology 2006; 104:631-633. An acute evaluation on new insights disclosed by this innovative chelating drug.